Evidence map›Paper›PMID 37235072›Full record

ArticleInfection and drug resistance2023

Association of Single-Nucleotide Polymorphisms in the

Jinjie Yu, Mengwen Liu, Xiaokaiti Mijiti, Haican Liu, Quan Wang, Chunjie Yin, Aiketaguli Anwaierjiang, Miao Xu, Machao Li, Lele Deng and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Association of vitamin D receptorJournal of clinical tuberculosis and other mycobacterial diseases · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jinjie Yu *School of Public Health, University of South China, Hengyang, 421001, People's Republic of China.
Mengwen Liu *School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China.
Xiaokaiti Mijiti *The Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China.
Haican Liu *State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.ORCID 0000-0002-9420-1211
Quan WangThe Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China.
Chunjie YinSchool of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China.
Aiketaguli AnwaierjiangCollege of Xinjiang Uyghur Medicine, Hetian, 848000, People's Republic of China.
Miao XuThe Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China.
Machao LiState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.
Lele DengState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.
Hui XiaoSchool of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China.
Xiuqin ZhaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.
Kanglin WanState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.
Guilian LiState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.
Xiuqin YuanSchool of Public Health, University of South China, Hengyang, 421001, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aim of the present study was to investigate the association between vitamin D receptor ( Methods: From January 2019 to January 2020, we enrolled 221 tuberculosis patients as the case group and 363 staff with no clinical symptoms as the control group from four designated tuberculosis hospitals in southern Xinjiang, China. The polymorphisms of Fok I, Taq I, Apa I, Bsm I, rs3847987 and rs739837 in the Results: Our results showed that the allele and genotype frequencies of Fok I, Taq I, Apa I, Bsm I, rs3847987 and rs739837 in Conclusion: Polymorphisms in the

Indexed as

Beijing lineageMycobacterium tuberculosispolymorphismtuberculosisVDRvitamin D receptor

Identifiers

PMID37235072
PMCPMC10208660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.